AAP
NARI

Arax Advisory Partners’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Arax Advisory Partners’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14
Closed -$715 – 3112
2024
Q4 		$715 Buy
+14
New +$688 ﹤0.01% 2246

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Arax Advisory Partners's NARI Position: Q1 2025 in Review

Arax Advisory Partners sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 14 shares — an estimated $715 sold.

Arax Advisory Partners first reported a position in NARI in Q4 2024 and held it in 1 quarter. The position peaked at $715 in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Arax Advisory Partners reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Arax Advisory Partners sold 14 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $715.
  • Arax Advisory Partners first reported a position in Inari Medical, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • Arax Advisory Partners's Inari Medical, Inc. Common Stock position peaked at $715 in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Arax Advisory Partners's 13F filing for Q1 2025, filed 15 May 2025.